About Hdl Therapeutics
Hdl Therapeutics is a private company based in Vero Beach, Florida. It has reported $17,790,395 raised in six offerings on Form D since February 2013.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 22, 2023 | Jul 10, 2023 | $1,270,074of $7.0M target | 15 | $84,672 | Equity, Series X Preferred SharesRule 506(b) | Form D ↗ |
| Feb 19, 2021 | Mar 4, 2021 | $3,355,237of $50.0M target | 31 | $108K | Equity, Series E Preferred StockRule 506(b) | Form D ↗ |
| Sep 19, 2019 | Oct 3, 2019 | $3,000,019of $3.0M target | 34 | $88,236 | Equity, Series D Preferred StockRule 506(b) | Form D ↗ |
| Aug 5, 2016 | Sep 14, 2016amended May 10, 2017 | $7,195,065of $12.0M target | 57 | $126K | Equity, Series C Preferred StockRule 506(b) | Form D/A ↗1 earlier filing |
| May 2, 2014 | Dec 31, 2014 | $2,045,000of $4.5M target | 14 | $146K | Equity, Series B Preferred StockRule 506(b) | Form D ↗ |
| Jan 31, 2013 | Feb 13, 2013 | $925,000of $1.5M target | 10 | $92,500 | Equity, Series A Preferred Stock06 | Form D ↗ |
| Total, six offerings | $17,790,395 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Hdl Therapeutics's Form D filed Jul 10, 2023.
MM
Michael Matin
Executive officer
GS
Gregg Sessa
Director
DA
Dane Andreeff
Director
BB
Bryan Brewer
Executive officer